Regional [18F]flortaucipir PET is more closely associated with disease severity than CSF p-tau in Alzheimer’s disease

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1619-7089

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Regional [18F]flortaucipir PET is more closely associated with disease severity than CSF p-tau in Alzheimer’s disease ; day:14 ; month:4 ; year:2020 ; pages:1-13
European journal of nuclear medicine and molecular imaging ; (14.4.2020), 1-13

Creator: Wolters, Emma E.
Ossenkoppele, Rik
Verfaillie, Sander C. J.
Coomans, Emma M.
Timmers, Tessa
Visser, Denise
Tuncel, Hayel
Golla, Sandeep S. V.
Windhorst, Albert D.
Boellaard, Ronald
Flier, Wiesje M. van der
Teunissen, Charlotte E.
Scheltens, Philip
Berckel, Bart N. M. van

Contributor: SpringerLink (Online service)

DOI: 10.1007/s00259-020-04758-2

URN: urn:nbn:de:101:1-2020071621174769895808

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:03 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Wolters, Emma E.
Ossenkoppele, Rik
Verfaillie, Sander C. J.
Coomans, Emma M.
Timmers, Tessa
Visser, Denise
Tuncel, Hayel
Golla, Sandeep S. V.
Windhorst, Albert D.
Boellaard, Ronald
Flier, Wiesje M. van der
Teunissen, Charlotte E.
Scheltens, Philip
Berckel, Bart N. M. van
SpringerLink (Online service)

Other Objects (12)

Heterogeneity of Alzheimer’s disease: consequence for drug trials?

The “rights” of precision drug development for Alzheimer’s disease

Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer’s disease spectrum

A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future

The plasma peptides of Alzheimer’s disease

Clinical Features of Patients with Alzheimer’s Disease and a History of Traumatic Brain Injury

Reproducibility of EEG functional connectivity in Alzheimer’s disease

Tau pathology and relative cerebral blood flow are independently associated with cognition in Alzheimer’s disease

Eyes-closed task-free electroencephalography in clinical trials for Alzheimer’s disease: an emerging method based upon brain dynamics

Differential associations between neocortical tau pathology and blood flow with cognitive deficits in early-onset vs late-onset Alzheimer’s disease

Declining functional connectivity and changing hub locations in Alzheimer’s disease: an EEG study

Sensitive and reproducible MEG resting-state metrics of functional connectivity in Alzheimer’s disease

Heterogeneity of Alzheimer’s disease: consequence for drug trials?

The “rights” of precision drug development for Alzheimer’s disease

Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer’s disease spectrum

A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future

The plasma peptides of Alzheimer’s disease

Clinical Features of Patients with Alzheimer’s Disease and a History of Traumatic Brain Injury

Reproducibility of EEG functional connectivity in Alzheimer’s disease

Tau pathology and relative cerebral blood flow are independently associated with cognition in Alzheimer’s disease

Eyes-closed task-free electroencephalography in clinical trials for Alzheimer’s disease: an emerging method based upon brain dynamics

Differential associations between neocortical tau pathology and blood flow with cognitive deficits in early-onset vs late-onset Alzheimer’s disease

Declining functional connectivity and changing hub locations in Alzheimer’s disease: an EEG study

Sensitive and reproducible MEG resting-state metrics of functional connectivity in Alzheimer’s disease

Heterogeneity of Alzheimer’s disease: consequence for drug trials?

The “rights” of precision drug development for Alzheimer’s disease

Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer’s disease spectrum

A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future

The plasma peptides of Alzheimer’s disease

Clinical Features of Patients with Alzheimer’s Disease and a History of Traumatic Brain Injury

Reproducibility of EEG functional connectivity in Alzheimer’s disease

Tau pathology and relative cerebral blood flow are independently associated with cognition in Alzheimer’s disease

Eyes-closed task-free electroencephalography in clinical trials for Alzheimer’s disease: an emerging method based upon brain dynamics

Differential associations between neocortical tau pathology and blood flow with cognitive deficits in early-onset vs late-onset Alzheimer’s disease

Declining functional connectivity and changing hub locations in Alzheimer’s disease: an EEG study

Sensitive and reproducible MEG resting-state metrics of functional connectivity in Alzheimer’s disease

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Regional [18F]flortaucipir PET is more closely associated with disease severity than CSF p-tau in Alzheimer’s disease

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Heterogeneity of Alzheimer’s disease: consequence for drug trials?

The “rights” of precision drug development for Alzheimer’s disease

Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer’s disease spectrum

A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future

The plasma peptides of Alzheimer’s disease

Clinical Features of Patients with Alzheimer’s Disease and a History of Traumatic Brain Injury

Reproducibility of EEG functional connectivity in Alzheimer’s disease

Tau pathology and relative cerebral blood flow are independently associated with cognition in Alzheimer’s disease

Eyes-closed task-free electroencephalography in clinical trials for Alzheimer’s disease: an emerging method based upon brain dynamics

Differential associations between neocortical tau pathology and blood flow with cognitive deficits in early-onset vs late-onset Alzheimer’s disease

Declining functional connectivity and changing hub locations in Alzheimer’s disease: an EEG study

Sensitive and reproducible MEG resting-state metrics of functional connectivity in Alzheimer’s disease

Heterogeneity of Alzheimer’s disease: consequence for drug trials?

The “rights” of precision drug development for Alzheimer’s disease

Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer’s disease spectrum

A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future

The plasma peptides of Alzheimer’s disease

Clinical Features of Patients with Alzheimer’s Disease and a History of Traumatic Brain Injury

Reproducibility of EEG functional connectivity in Alzheimer’s disease

Tau pathology and relative cerebral blood flow are independently associated with cognition in Alzheimer’s disease

Eyes-closed task-free electroencephalography in clinical trials for Alzheimer’s disease: an emerging method based upon brain dynamics

Differential associations between neocortical tau pathology and blood flow with cognitive deficits in early-onset vs late-onset Alzheimer’s disease

Declining functional connectivity and changing hub locations in Alzheimer’s disease: an EEG study

Sensitive and reproducible MEG resting-state metrics of functional connectivity in Alzheimer’s disease

Heterogeneity of Alzheimer’s disease: consequence for drug trials?

The “rights” of precision drug development for Alzheimer’s disease

Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer’s disease spectrum

A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future

The plasma peptides of Alzheimer’s disease

Clinical Features of Patients with Alzheimer’s Disease and a History of Traumatic Brain Injury

Reproducibility of EEG functional connectivity in Alzheimer’s disease

Tau pathology and relative cerebral blood flow are independently associated with cognition in Alzheimer’s disease

Eyes-closed task-free electroencephalography in clinical trials for Alzheimer’s disease: an emerging method based upon brain dynamics

Differential associations between neocortical tau pathology and blood flow with cognitive deficits in early-onset vs late-onset Alzheimer’s disease

Declining functional connectivity and changing hub locations in Alzheimer’s disease: an EEG study

Sensitive and reproducible MEG resting-state metrics of functional connectivity in Alzheimer’s disease

Related objects

Reset password